skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:064144/0596   Pages: 3
Recorded: 06/27/2023
Conveyance: ASSIGNEE CHANGE OF ADDRESS
Total properties: 9
1
Patent #:
NONE
Issue Dt:
Application #:
16824585
Filing Dt:
03/19/2020
Publication #:
Pub Dt:
09/24/2020
Title:
Combination Therapy Using a Chemokine Receptor 2 (CCR2) Antagonist and a PD-1 and/or PD-L1 Inhibitor
2
Patent #:
Issue Dt:
01/30/2024
Application #:
17219172
Filing Dt:
03/31/2021
Publication #:
Pub Dt:
10/07/2021
Title:
COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE USING CCR9 INHIBITOR AND ANTI-IL-23 BLOCKING ANTIBODIES
3
Patent #:
Issue Dt:
07/04/2023
Application #:
17338502
Filing Dt:
06/03/2021
Publication #:
Pub Dt:
04/21/2022
Title:
MACROCYCLIC IMMUNOMODULATORS
4
Patent #:
NONE
Issue Dt:
Application #:
17354003
Filing Dt:
06/22/2021
Publication #:
Pub Dt:
12/23/2021
Title:
METHODS OF TREATING CANCER USING HETEROARYL-BIPHENYL AMIDE DERIVATIVES
5
Patent #:
Issue Dt:
09/19/2023
Application #:
17460716
Filing Dt:
08/30/2021
Publication #:
Pub Dt:
06/09/2022
Title:
INDANE-AMINES AS PD-L1 ANTAGONISTS
6
Patent #:
NONE
Issue Dt:
Application #:
17576144
Filing Dt:
01/14/2022
Publication #:
Pub Dt:
02/09/2023
Title:
TRIARYL COMPOUNDS FOR TREATMENT OF PD-L1 DISEASES
7
Patent #:
NONE
Issue Dt:
Application #:
17694829
Filing Dt:
03/15/2022
Publication #:
Pub Dt:
01/26/2023
Title:
COMBINATION THERAPY USING A CHEMOKINE RECEPTOR 2 (CCR2) ANTAGONIST AND A PD-1/PD-L1 INHIBITOR
8
Patent #:
NONE
Issue Dt:
Application #:
17816614
Filing Dt:
08/01/2022
Publication #:
Pub Dt:
04/20/2023
Title:
2-OXINDOLE COMPOUNDS
9
Patent #:
Issue Dt:
10/24/2023
Application #:
17838400
Filing Dt:
06/13/2022
Publication #:
Pub Dt:
04/20/2023
Title:
IMMUNOMODULATOR COMPOUNDS
Assignor
1
Exec Dt:
06/23/2023
Assignee
1
ONE AMGEN CENTER DRIVE
THOUSAND OAKS, CALIFORNIA 91320-1799
Correspondence name and address
AMGEN INC.
ONE AMGEN CENTER DRIVE
MAIL STOP 28-5-A
THOUSAND OAKS, CA 91320-1799

Search Results as of: 05/28/2024 12:14 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT